Dec 15, 2025 05:40PM
Dec 15, 2025 05:39PM
Oct 17, 2025 05:05AM
Oct 16, 2025 03:24PM
Oct 16, 2025 03:19PM
Aug 4, 2025 04:30PM
Jun 24, 2025 07:00AM The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
Mar 13, 2025 06:07PM
May 15, 2023 09:10AM
May 15, 2023 09:08AM
Mar 8, 2023 04:45PM
Nov 3, 2022 04:36PM
Aug 4, 2022 04:30PM
Aug 1, 2022 04:31PM Cellectis (CLLS) Receives IND clearance for UCART20x22, its First in-house Manufactured Product Candidate for the Treatment of B-cell Malignancies
Aug 1, 2022 04:30PM
May 12, 2022 04:31PM
Mar 15, 2022 04:01PM
Mar 3, 2022 04:45PM
Jan 10, 2022 04:30PM
Aug 5, 2021 04:30PM
May 6, 2021 04:30PM Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Mar 4, 2021 04:42PM
Nov 17, 2020 08:00PM
Nov 5, 2020 04:35PM
Aug 19, 2020 09:26AM
Aug 5, 2020 04:30PM
Jul 7, 2020 09:32AM
Jul 6, 2020 05:57PM After-Hours Stock Movers 07/06: (GLDD) (XPSA) Higher; (MARK) (CLLS) (PING) Lower (more...)
Jul 6, 2020 04:33PM
Jul 6, 2020 04:33PM
Apr 30, 2020 08:31AM
Mar 4, 2020 04:30PM
Jan 21, 2020 08:35AM
Jan 21, 2020 08:31AM
Jan 15, 2020 04:30PM First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia
Jan 12, 2020 04:00PM
Nov 6, 2019 04:47PM
Nov 6, 2019 04:05PM
Oct 29, 2019 04:30PM
Oct 1, 2019 04:30PM
Aug 6, 2019 04:30PM
May 7, 2019 05:30PM Calyxt Reports 1st Quarter Financial Results
May 7, 2019 04:32PM
Apr 17, 2019 04:30PM
Apr 2, 2019 04:32PM
Apr 2, 2019 04:30PM
Mar 11, 2019 04:10PM
Mar 11, 2019 04:10PM
Mar 7, 2019 04:30PM Cellectis Enters Lease Agreement to Build Manufacturing Facility, Advancing Towards Commercialization of its UCART Portfolio
Feb 26, 2019 04:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All